CISA, FDA warn of new Illumina DNA device vulnerability

Several U.S. agencies warned this week about a vulnerability affecting software in devices used for DNA research that would allow hackers access to sensitive patient information.

The Food and Drug Administration (FDA) and the company behind the devices — Illumina — said they have not received any reports indicating the vulnerability has been exploited.

Illumina is one of the world’s biggest manufacturers of medical devices that handle bioanalysis and DNA sequencing.